Novavax Partners With Takeda to Sell Its Coronavirus Vaccine in Japan

Novavax (NASDAQ:NVAX) is teaming up with Japanese drug maker Takeda Pharmaceutical (NYSE:TAK) to sell Novavax's coronavirus vaccine, NVX-CoV2373, as a prevention for COVID-19 in Japan.